Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Blood-based liquid biopsy: Insights into early detection and clinical management of lung cancer
Cuiliu Liu et al.
CANCER LETTERS (2022)
Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer
Silvia Waldeck et al.
MOLECULAR ONCOLOGY (2022)
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)
Mariano Provencio et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Spatiotemporal genomic analysis reveals distinct molecular features in recurrent stage I non-small cell lung cancers
Kezhong Chen et al.
CELL REPORTS (2022)
KMT2C promoter methylation in plasma-circulating tumor DNA is a prognostic biomarker in non-small cell lung cancer
Sofia Mastoraki et al.
MOLECULAR ONCOLOGY (2021)
Liquid biopsy enters the clinic - implementation issues and future challenges
Michail Ignatiadis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients
Aliki Ntzifa et al.
SCIENTIFIC REPORTS (2021)
Circulating tumor cells can predict the prognosis of patients with non-small cell lung cancer after resection: a retrospective study
Zhao Li et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2021)
Evaluation of endocrine resistance using ESR1 genotyping of circulating tumor cells and plasma DNA
Tilak K. Sundaresan et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Detection of EGFR Mutations in Plasma cfDNA and Paired CTCs of NSCLC Patients before and after Osimertinib Therapy Using Crystal Digital PCR
Aliki Ntzifa et al.
CANCERS (2021)
Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-Stage Lung Cancer Diagnosis
Lingling Wan et al.
FRONTIERS IN ONCOLOGY (2021)
Hazards of Recurrence, Second Primary, or Other Tumor at Ten Years After Surgery for Non-Small-Cell Lung Cancer
Nicole Fink-Neuboeck et al.
CLINICAL LUNG CANCER (2020)
Direct comparison of size-dependent versus EpCAM-dependent CTC enrichment at the gene expression and DNA methylation level in head and neck squamous cell carcinoma
Martha Zavridou et al.
SCIENTIFIC REPORTS (2020)
Detection of EGFR Mutations in cfDNA and CTCs, and Comparison to Tumor Tissue in Non-Small-Cell-Lung-Cancer (NSCLC) Patients
Haiyan E. Liu et al.
FRONTIERS IN ONCOLOGY (2020)
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
F. Mosele et al.
ANNALS OF ONCOLOGY (2020)
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer
C. R. Lindsay et al.
EUROPEAN JOURNAL OF CANCER (2019)
Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer A Review
Kathryn C. Arbour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study
Yung-Hung Luo et al.
LANCET ONCOLOGY (2019)
How liquid biopsies can change clinical practice in oncology
G. Siravegna et al.
ANNALS OF ONCOLOGY (2019)
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse
Francesca Chemi et al.
NATURE MEDICINE (2019)
Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection
Christopher Abbosh et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis
Sean P. Pitroda et al.
NATURE COMMUNICATIONS (2018)
Challenges in using liquid biopsies for gene expression profiling
Tania B. Porras et al.
Oncotarget (2018)
Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR
Charles Decraene et al.
CLINICAL CHEMISTRY (2018)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh et al.
NATURE (2017)
Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
Collin M. Blakely et al.
NATURE GENETICS (2017)
Tracking the Evolution of Non-Small-Cell Lung Cancer
M. Jamal-Hanjani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant Geparquattro Trial
Sabine Riethdorf et al.
CLINICAL CANCER RESEARCH (2017)
Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses
Tilak K. Sundaresan et al.
CLINICAL CANCER RESEARCH (2016)
Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer
M. Jamal-Hanjani et al.
ANNALS OF ONCOLOGY (2016)
A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells
G. E. Hvichia et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)
Fabrice Barlesi et al.
LANCET (2016)
Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing
Ke-Zhong Chen et al.
SCIENTIFIC REPORTS (2016)
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
Nicholas McGranahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
Jianjun Zhang et al.
SCIENCE (2014)
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
Elza C. de Bruin et al.
SCIENCE (2014)
SOX17 Promoter Methylation in Circulating Tumor Cells and Matched Cell-Free DNA Isolated from Plasma of Patients with Breast Cancer
Maria Chimonidou et al.
CLINICAL CHEMISTRY (2013)
Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non-Small-Cell Lung Cancer
Emma Pailler et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
DNA Methylation of Tumor Suppressor and Metastasis Suppressor Genes in Circulating Tumor Cells
Maria Chimonidou et al.
CLINICAL CHEMISTRY (2011)
PIK3CA Hotspot Mutation Scanning by a Novel and Highly Sensitive High-Resolution Small Amplicon Melting Analysis Method
Panagiotis A. Vorkas et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Share Paper
